SOLENO THERAPEUTICS INC Annual Payments to Acquire Property, Plant, and Equipment in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Soleno Therapeutics Inc quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2013 to 2023.
  • Soleno Therapeutics Inc Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $11K.
  • Soleno Therapeutics Inc annual Payments to Acquire Property, Plant, and Equipment for 2023 was $0.000, a 100% decline from 2022.
  • Soleno Therapeutics Inc annual Payments to Acquire Property, Plant, and Equipment for 2022 was $13K, a 40.9% decline from 2021.
  • Soleno Therapeutics Inc annual Payments to Acquire Property, Plant, and Equipment for 2021 was $22K, a 214% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$13K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $13K -$9K -40.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $22K +$15K +214% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $7K -$14K -66.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $21K +$13K +163% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
2018 $8K +$6K +300% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 $2K -$12.8K -86.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-20
2016 $14.8K -$41K -73.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $55.8K +$25.1K +81.8% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
2014 $30.7K +$29.4K +2308% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
2013 $1.27K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.